Aberrant casein kinase II in Alzheimer's disease

[1]  E. Masliah,et al.  An antiserum against amyloid β-protein precursor detects a unique peptide in Alzheimer brain , 1989, Neuroscience Letters.

[2]  K. Jellinger,et al.  Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.

[3]  P. Ruzza,et al.  Synthetic peptide substrates for casein kinase 2. Assessment of minimum structural requirements for phosphorylation. , 1988, Biochimica et biophysica acta.

[4]  L. Pinna,et al.  Phosphorylation of phosvitin by casein kinase-2 provides the evidence that phosphoserines can replace carboxylic amino acids as specificity determinants. , 1988, Biochimica et biophysica acta.

[5]  L. Pinna,et al.  Partially dephosphorylated phosphopeptide AcSer(P)‐Ser(P)‐Ser(P) is an excellent substrate for casein kinase‐2 , 1988, FEBS letters.

[6]  P. Cohen.  Review Lecture: Protein phosphorylation and hormone action , 1988, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[7]  K. Dobkins,et al.  Decreased levels of protein kinase C in Alzheimer brain , 1988, Brain Research.

[8]  J. Walker,et al.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. A. Anderer,et al.  Casein kinase II accumulation in the nucleolus and its role in nucleolar phosphorylation. , 1988, Biochimica et biophysica acta.

[10]  H. Braak,et al.  Neuropil Threads Occur in Dendrites of Tangle—Bearing Nerve Cells , 1988, Neuropathology and applied neurobiology.

[11]  K. Kosik,et al.  Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease , 1987, Annals of neurology.

[12]  K. Dobkins,et al.  Protein kinase C in human brain and its inhibition by calmodulin , 1986, Brain Research.

[13]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Hathaway,et al.  Regulation of casein kinase II by 2,3-bisphosphoglycerate in erythroid cells. , 1984, The Journal of biological chemistry.

[15]  R. Terry,et al.  Senile dementia of the Alzheimer type , 1983, Annals of neurology.

[16]  L. Pinna,et al.  Polyglutamyl peptides: a new class of inhibitors of type‐2 casein kinases , 1983, FEBS letters.

[17]  M. Dahmus.  Calf thymus RNA polymerases I and II do not contain subunits structurally related to casein kinases I and II. , 1981, The Journal of biological chemistry.

[18]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[19]  G. Hathaway,et al.  Inhibition of casein kinase II by heparin. , 1980, The Journal of biological chemistry.

[20]  P. Greengard.  Phosphorylated proteins as physiological effectors. , 1978, Science.

[21]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[22]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology , 1987 .

[23]  Y. Ihara,et al.  Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. , 1986, Journal of biochemistry.

[24]  G. Hathaway,et al.  Casein kinases--multipotential protein kinases. , 1982, Current topics in cellular regulation.

[25]  E. Krebs,et al.  Phosphorylation-dephosphorylation of enzymes. , 1979, Annual review of biochemistry.